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Objective: In primary hyperparathyroidism (PHPT), vertebral fractures (VFx) occur regardless of bone
mineral density (BMD) and may depend on decreased bone quality. Trabecular bone score (TBS) is a
texture measurement acquired during a spinal dual-energy X-ray absorptiometry (DXA). Recently, TBS
has been proposed as an index of bone micro-architecture.
Design: We studied 92 PHPT patients (74 females, age 62.1G9.7 years) and 98 control subjects. In all
patients at baseline, in 20 surgically treated patients and in 10 conservatively treated patients after
24 months, TBS, spinal (lumbar spine (LS)) and femoral (total hip (TH) and femoral neck (FN)) BMD
were assessed by DXA and VFx by spinal radiograph.
Results: PHPT patients had lower TBS (K2.39G1.8) and higher VFx prevalence (43.5%) than controls
(K0.98G1.07 and 8.2% respectively, both P!0.0001). TBS was associated with VFx (odds ratio 1.4,
95% CI 1.1–1.9, PZ0.02), regardless of LS-BMD, age, BMI and gender, and showed a better
compromise between sensitivity (75%) and specificity (61.5%) for detecting VFx than LS-BMD,
TH-BMD and FN-BMD (31 and 75%, 72 and 44.2%, and 64 and 65% respectively). In surgically
treated patients, TBS, LS-BMD, TH-BMD and FN-BMD increased (C47G44.8,C29.2
G34.1,C49.4G48.7 and C30.2G39.3% respectively, all P!0.0001). Among patients treated
conservatively, TBS decreased significantly in those (nZ3) with incident VFx (K1.3G0.3) compared
with those without (K0.01G0.9, PZ0.048), while BMD changes were not statistically different (LS
0.3G1.2 vsK0.8G0.9 respectively, PZ0.19; TH 0.4G0.8 vsK0.8G1.4 respectively, PZ0.13 and
FN 0.4G0.9 vs K0.8G1.4 respectively, PZ0.14).
Conclusions: In PHPT, bone quality, as measured by TBS, is reduced and associated with VFx and
improves after surgery.
European Journal of Endocrinology 169 155–162Introduction
Primary hyperparathyroidism (PHPT) is a common
endocrine disease with a prevalence of 3% in the general
population (1) and of 2.5–3% in womenO65 years of age
(2). It is known that PHPT leads to bone loss and increased
fracture risk, which are particularly pronounced at sites
rich in cortical bone (3, 4, 5, 6). Despite the preferential
involvement of cortical bone in PHPT, an increased rate of
vertebral fractures (VFx) has been reported in patients
with PHPT (7, 8, 9). In these subjects, the evaluation of
bone mineral density (BMD) at the spine does not reliably
mirror the increased risk of fractures (8, 9), and a
deterioration of bone quality (trabecular number, thick-
ness and connectivity) has been advocated as a
contributor to the increased VFx risk (10).ndocrinologyTo date, bone micro-architecture can be directly
assessed only by histomorphometric or microCT
analysis of an invasively obtained bone biopsy sample
or by high-resolution peripheral quantitative computed
tomography (11, 12), which is, however, impractical
for routine clinical management.
The trabecular bone score (TBS) is a grey-level texture
measurement based on the use of experimental
variograms of two-dimensional (2D) projection images
acquired during a dual-energy X-ray absorptiometry
(DXA) lumbar spine (LS) scan (13). It may be used for
the routine evaluation of bone micro-architecture, as
it is strongly correlated with bone micro-architecture,
regardless of BMD (14, 15). Several studies suggested
the usefulness of TBS in addition to BMD to identify
patients with postmenopausal osteoporosis at higherDOI: 10.1530/EJE-13-0305
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been documented to be useful as an adjunctive tool in
assessing the risk of fracture in patients with secondary
forms of osteoporosis (21, 22), which are typically
characterized by a reduction of bone quality (23).
Recently, TBS has been found to be more accurate
than spinal BMD for identifying PHPT patients at risk
for VFx (24) and to be associated with trabecular micro-
architecture as assessed by high-resolution peripheral
quantitative computed tomography (25).
Therefore, the aim of this study was to evaluate the
usefulness of TBS alone or in combination with BMD for
predicting VFx in PHPT patients before and after
surgery or a conservative follow-up.Subjects and methods
Subjects
This prospective observational study was performed at
‘Fondazione IRCCS Ca` Granda’ (Milan). From January
2010 to December 2011, 92 Caucasian patients
(74 postmenopausal females and 18 eugonadal males)
with PHPT were consecutively enrolled.
PHPT was diagnosed in the presence of hypercalcae-
mia and elevated or inappropriately normal parathyroid
hormone (PTH) levels, after the exclusion of a familial
hypocalciuric hypercalcaemia by the evaluation of
calcium clearance:creatinine clearance ratio in the
presence of normal renal function (26). The exclusion
criteria were i) past or current history of hypogonadism
(in males, testosterone levels !3.0 ng/ml in two
different samples; in females, occurrence of menopause
before 45 years) and of other diseases known to affect
bone metabolism (i.e. thyrotoxicosis, bowel diseases,
chronic renal failure, chronic hepatic disease,
depression, alcoholism, eating disorders and rheuma-
tological or haematological diseases); ii) administration
of drugs influencing bone metabolism or PTH and
calcium levels; iii) the presence of multiple endocrine
neoplasia type 1 syndrome, as in this condition, the
clinical presentation may be different compared with
sporadic PHPT (27) and iv) history of a possible high-
energy VFx.
Ninety-eight subjects (81 postmenopausal females
and 17 eugonadal males) served as controls. These
subjects were consecutively enrolled on the basis of the
above-mentioned exclusion criteria from our outpatient
clinics at which they were referred for unrelated
diseases (multinodular goitre with normal thyroid
function). In all control subjects with low BMD, a
routine screening was performed to exclude patients
with secondary osteoporosis in accordance with the
Italian Society for Osteoporosis, Mineral Metabolism
and Bone Diseases guidelines (28).
Among the whole group of PHPT patients, we also
report the available longitudinal data of 20 subjectswww.eje-online.org(19 females) after 24 months from surgery and recovery
from PHPT and of 10 subjects after 24 months of a
conservative follow-up. These subjects have been
consecutively included in an ongoing study protocol
aimed to assess the value of TBS in predicting the
incidence of fracture in PHPT patients. None of
these subjects took drugs that could interfere with
skeletal status.
Among these patients, surgery was not indicated in
seven subjects (25) on the basis of the criteria from the
3rd International Workshop on asymptomatic PHPT
(26), and it was refused in three patients. All surgically
treated patients had verified parathyroid adenomas
and/or hyperplasia and their calcium and PTH levels
normalized after surgery.
All subjects gave their witnessed informed consent
before entering the study, which was approved by Local
Ethics Committees and in accordance with Helsinki
Declaration II.Methods
Serum and urinary samples were collected and stored at
K20 8C until assayed. In all subjects, the following was
measured: blood cell count, serum calcium, creatinine,
intact PTH, 25-hydroxyvitamin D (25OHVitD), protein
electrophoresis and total testosterone (in males). Total
calcium was corrected for serum albumin according
to the formula: (total calciumC(4.4Kalbumin
mg/dl)!0.8) (reference interval 8.4–10.4 mg/dl,
2.1–2.5 mmol/l) (29). Urinary calcium and creatinine
were measured in 24-h urine collections and calcium
clearance was calculated in order to exclude the
presence of benign hypocalciuric hypercalcaemia.
Calcium, albumin, and creatinine in serum and
urinary calcium and creatinine were measured by
standard colorimetric techniques. Serum intact PTH
was measured by a chemiluminescent method (Nichols
Institute Diagnostic, San Juan Capistrano, CA, USA)
with intra- and interassay coefficient of variation (CV) of
5.1 and 8.2% respectively. Serum 25OHVitD levels were
measured by RIA (DiaSorin, Saluggia, Italy) with an
intra- and interassay CV of 5.6 and 15% respectively.
At the enrolment, all patients and controls with
25OHVitD levels !75 nmol/l received cholecalciferol
supplementation. An oral bolus of 100 000 or
300 000 IU of cholecalciferol was administered in
patients with 25OHVitD levels between 25 and
72.5 nmol/l, and !25 nmol/l respectively (28). All
patients included in the longitudinal arms of the study
received cholecalciferol supplementation throughout
the 24 months of follow-up, in order to maintain
25OHVitD levels above 75 nmol/l.
At the enrolment, in all patients and controls, BMD
was measured by DXA (Hologic Discovery, Software
version 13.3:3, Bedford MA, USA) at LS (precision
1.0%), total hip (TH, precision 1.7%) and femoral neckDownloaded from Bioscientifica.com at 10/22/2019 08:57:44AM
via Universita Degli Studi di Milano
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expressed as S.D. units (Z values) in relation to reference
population (30). Fractured vertebrae were excluded
from BMD measurement.
At the enrolment, in all patients, conventional spinal
radiographs (T4–L4) in lateral and antero-posterior
projection were obtained with standardized technique
in all subjects. Two trained physicians, who were
blinded to BMD and hormonal data, independently
reviewed the radiographs. The radiologists discussed
questionable cases to agree on a diagnosis. VFx were
diagnosed on visual inspection using the semiquantita-
tive (SQ) visual assessment, previously described by
Genant et al. (31). According to this technique,
fractures assessed on lateral thoraco-LS radiographs
were defined as reductions of more than 20% in
anterior, middle or posterior vertebral height. From
lateral spine radiographs, each vertebra is visually
assessed as intact (SQ grade 0) or as having approxi-
mately mild (20–25% compression), moderate
(25–40% compression) or severe (O40% compression)
deformity (SQ grades 1, 2 and 3 respectively).
Subsequently, for each subject, the spinal deformity
index (SDI) was calculated by summing the SQ grade
for each of the 13 vertebrae from T4 to L4
(SDIZSQT4C.CSQT12CSQL1C.CSQL4) (32, 33).
In all patients and controls, TBS was assessed in the
region of LS-BMD according to previously described
methods (22). Briefly, the TBS is a grey-level texture
measurement based on the use of experimental
variograms of 2D projection images acquired during a
LS scan. An empirical 3D/2D relationship has been
established that expresses the TBS as a function of two
3D bone characteristics: solid volume fraction and mean
solid thickness (15). TBS is able to differentiate between
two 3D micro-architectures that exhibit the same bone
density, with different trabecular characteristics. This
evaluation is constrained by neither the size nor the
shape of the region being measured. TBS is, therefore, a
texture measurement for small and/or irregular
surfaces of analysis, such as the standard region of
measurement defined in DXA images. Higher TBS may
reflect strong, fracture-resistant micro-architecture,
whereas a low TBS may reflect weak, fracture-prone
micro-architecture (16, 18). In order to normalize
TBS values for age, TBS data were reported as S.D.
units (Z-scores) in relation to the French reference
population (34).Statistical analysis
Statistical analysis was performed by SPSS version 12.0
statistical package (SPSS, Inc.). The results are
expressed as meanGS.D. The normality of distribution
was tested by Kolmogorov–Smirnov test.
The comparison of continuous variables between
PHPT patients and controls was performed using
Student’s t-test or Mann–Whitney U test as appropriate.Categorical variables were compared by c2 test or by
Fisher exact test as appropriate. The associations
between the calcium metabolism parameters, TBS,
age, years since menopause, SDI and LS-BMD,
FN-BMD and TH-BMD were tested by either Pearson’s
product–moment correlation or Spearman’s correlation
as appropriate.
The logistic regression analysis assessed in PHPT
patients the association between the presence of
a prevalent fracture (dependent variables, expressed
as categorical variables) and TBS after adjusting for
the following independent variables: age or years
since menopause, BMI, gender and LS-BMD.
The receiver operating characteristic (ROC) curve
analysis was performed to assess the best cut-offs of TBS
and LS-BMD, TH-BMD and FN-BMD for detecting PHPT
patients with prevalent VFx. On the basis of these
cut-offs, sensitivity (SN), specificity (SP) and overall
accuracy of TBS, LS-BMD, TH-BMD and FN-BMD and of
the combinations low TBS plus low BMD (at LS or TH or
FN or at any site) and of low TBS or low BMD (at LS
or TH or FN or at any site) were calculated. P values of
!0.05 were considered significant.Results
Cross-sectional arm of the study: comparison
between PHPT patients and controls
The clinical and biochemical characteristic of patients
and controls before 25OHVitD level normalization are
reported in Table 1. Age, BMI, years since menopause,
gender and 25OHVitD levels were not different between
PHPT patients and controls. Patients showed lower TBS,
LS-BMD, TH-BMD and FN-BMD levels and higher SDI
and prevalence of VFx.Accuracy of TBS, LS-BMD, TH-BMD and
FN-BMD in detecting PHPT patients with VFx
The bivariate correlation analysis showed that TBS was
associated with LS-BMD (rZ0.27, PZ0.011) and SDI
(RZK0.31, PZ0.003) but not with any parameter of
calcium metabolism, BMI or years since menopause.
The logistic regression analysis showed that the
presence of a VFx was associated with TBS (odds ratio
(OR) 1.4, 95% CI 1.1–1.9, PZ0.02), regardless of
LS-BMD (OR 1.2, 95% CI 0.7–1.9, PZ0.52), age
(OR 1.0, 95% CI 0.9–1.1, PZ0.11), BMI (OR 1.0,
95% CI 0.9–1.2, PZ0.6) and gender (OR 2.9, 95% CI
0.8–11.1, PZ0.12). The same analysis showed that the
number of years since menopause was not associated
with VFx and did not modify the results (TBS OR 1.6,
95% CI 1.21–2.2, PZ0.001; LS-BMD OR 1.8, 95% CI
1.1–2.9, PZ0.015; years since menopause OR 1.0
95% CI 0.9–1.1, PZ0.147; BMI OR 1.0, 95% CI
0.9–1.1, PZ0.512).www.eje-online.org
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Table 1 Clinical and biochemical characteristics of patients with PHPT and control subjects. Data are meanGS.D. with range in parenthesis
or absolute number with percentage in parenthesis. The data reported are obtained before cholecalciferol supplementation.
Controls (nZ98) PHPT (nZ92) P
Age (years) 62.1G9.7 (45.6 to 80.0) 62.7G10.1 (40.0 to 82.0) 0.670
BMI (kg/m2) 27.0G3.8 (20.5 to 36.4) 26.2G4.5 (19.0 to 35.0) 0.253
Females/males 81/17 (82.7/17.3) 74/18 (80.4/19.6) 0.712
YSM (years) 13.6G9.2 (1.0 to 33.0) 13.5G8.6 (1.0 to 31.5) 0.99
25-Hydroxyvitamin D (nmol/l) 69G23 (41.3 to 164.5) 71G29.3 (37 to 157.5) 0.631
PTH (ng/l) 48.4G14.4 (16.1 to 79) 151.5G105.9 (42 to 638) !0.0001
Serum calcium (mmol/l) 2.3G0.1 (2.1 to 2.6) 2.8G0.2 (2.6 to 3.9) !0.0001
No. of patients with calcium
O2.85 mmol/la
– 32 (34.8) –
Urinary calcium 24 h (mmol/day) 4.2G1.8 (1.8 to 8) 8.1G4.4 (2.5 to 28) !0.0001
Urinary calcium 24 h/kg (mmol/day) 0.06G0.03 (0.03 to 0.1) 0.12G0.06 (0.03 to 0.4) !0.0001
Creatinine clearance (ml/min) – 88.2G22.3 (50 to 144) –
No. of patients with creatinine clearance
!60 ml/min
– 11 (12) –
LS-BMD (Z-score) 0.51G1.46 (K2.00 to 4.10) K0.73G1.14 (K3.80 to 2.80) !0.0001
TH-BMD (Z-score) 0.22G0.83 (K1.50 to 2.10) K0.48G0.93 (K2.50 to 1.40) !0.0001
FN-BMD (Z-score) 0.05G0.85 (K2.60 to 2.70) K0.69G0.84 (K2.50 to 1.90) !0.0001
TBS (Z-score) K0.98G1.07 (K2.51 to 1.99) K2.39G1.79 (K6.55 to 1.97) !0.0001
No. of patients with vertebral fractures 8 (8.2) 40 (43.5) !0.0001
SDI 0.09G0.32 (0 to 2) 1.03G1.79 (0 to 9) !0.0001
No. of patients with nephrolithiasis – 44 (47.8) –
BMD, bone mineral density; LS, lumbar spine; TH, total femur; FN, femoral neck; TBS, trabecular bone score; SDI, spinal deformity index, sum of the fracture
grades of all vertebrae (T4–L4), assigning for each vertebra a visual semiquantitative grades of 0, 1, 2 or 3 for no fracture or mild, moderate or severe fracture
respectively; PTH, parathyroid hormone. Urinary calcium 24 h/kg, urinary calcium 24 h corrected for weight; YSM, years since menopause.
a0.25 mmol/l above the upper normal limit.
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threshold values of TBS, LS-BMD, TH-BMD and
FN-BMD for predicting VFx, showed that TBS,
LS-BMD, TH-BMD and FN-BMD have a moderate
accuracy for predicting VFx (area under the ROC
curve 0.74, 0.7, 0.67 and 0.71 respectively,
P!0.0001 for all analyses). The cut-offs with the best
compromise between SN and SP were set at K2.1 for
TBS,K0.3 for LS-BMD,K0.2 for TH-BMD and -0.6 for
FN-BMD (expressed as Z-scores). The SN, SP and overall
accuracy for predicting VFx of low TBS (i.e. !K2.1),
low LS-BMD (i.e. !K0.3), low TH-BMD (i.e.!K0.2),
low FN-BMD (i.e.!K0.6); of the combinations low TBS
plus low LS-BMD or TH-BMD or FN-BMD or low BMD at
any site; and of the combinations low TBS or low
LS-BMD, or TH-BMD or FN-BMD or low BMD at any site
are reported in Table 2. Low TBS showed higher
accuracy than low LS-BMD, TH-BMD and FN-BMD for
detecting patients with fractures. However, compared
with TBS alone, the combination low TBS plus low
FN-BMD had higher SP and slightly higher accuracy,
but lower SN for detecting patients with VFx. The
presence of the combinations low TBS or low TH-BMD
and low TBS or low FN-BMD showed a 95% SN, but a
23.1 and a 28.8% SP respectively, for detecting patients
at risk of fractures (Table 2). Indeed, only two of the 40
PHPT patients with fractures did not show low TBS
and/or low FN-BMD (false negative), but, on the other
hand, 37 out of the 52 patients without VFx showed, in
fact, low TBS and/or low FN-BMD, being, therefore, false
positive (Fig. 1).www.eje-online.orgLongitudinal arm of the study: effect of
surgical and conservative treatment
on TBS, BMD and VFx in PHPT patients
The biochemical and clinical characteristics at baseline
and after 24 months of follow-up of the 20 patients
operated on (19 females and one male, surgical group)
and the ten patients conservatively treated (seven
females and three males, conservative group) are
reported in Table 3.
In the surgical group, no patient experienced new
VFx and, after 24 months, BMD (at both spine and
femur) improved and TBS increased significantly,
although still remaining lower compared with controls
(Fig. 2). The mean Z-scores increase was higher for TBS
(1.2G1.6) compared with LS (0.4G0.7, PZ0.026), TH
(0.1G0.9, PZ0.01) and FN (0.1G0.9, PZ0.01), while
it was comparable among LS, TH and FN.
In the conservative group, three subjects experienced a
new VFx, BMD remained stable at spine (mean Z-score
decreaseK0.01G1.2) and femur (mean Z-score decrease
TH 0.03G1.1, FN 0.01G1.1), while mean TBS values
decreased (K0.4G0.97), even if without reaching the
statistical significance (Fig. 2). In the three patients
experiencing a VFx during the follow-up, TBS significantly
decreased (K1.3G0.3) as compared with the seven
patients without a new VFx (K0.01G0.9, PZ0.048). At
variance, the BMD decrease was not statistically different
between conservatively treated patients with and without
a new VFx (LS K0.8G0.9 vs 0.3G1.2 respectively,
PZ0.19; TH K0.8G1.4 vs 0.4G0.8 respectively,Downloaded from Bioscientifica.com at 10/22/2019 08:57:44AM
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Table 2 Diagnostic accuracy of low TBS and low BMD (at spine
and/or femur), taken alone or in combination, for detecting PHPT
patients with prevalent vertebral fracture. Data are expressed
as percentage. Low TBS and low BMD were defined on the basis
of the cut-offs obtained by ROC analysis (see text). These cut-offs
represent the best compromise between sensitivity and specificity
and were set at K2.0 for TBS, K0.3 for LS-BMD, K0.2 for
TH-BMD and K0.6 for FN-BMD (expressed as Z-scores).
Parameters of HPA axis activity
Sensi-
tivity
Speci-
ficity Accuracy
Low TBS 75 61.5 67.4
Low LS-BMD 75 30.8 50
Low TH-BMD 72.5 44.2 56.5
Low FN-BMD 70 50 58.7
Low TBS plus low LS-BMD 60 67.3 64
Low TBS plus low TH-BMD 47.5 80.8 66.3
Low TBS plus low FN-BMD 52.5 86.5 71.7
Low TBS plus low BMD at any site 62.5 65.4 64
Low TBS or low LS-BMD 90 25 53.3
Low TBS or low TH-BMD 95 23.1 54.3
Low TBS or low FN-BMD 95 28.8 57.6
TBS, trabecular bone score; LS, lumbar spine; TH, total hip; FN, femoral
neck; BMD, bone mineral density.
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Figure 1 Usefulness of the combination of trabecular bone score
(TBS) and femoral neck (FN)-bone mineral density (BMD)
(expressed as Z-score) in identifying patients with prevalent
asymptomatic vertebral fractures. The dark bars represent the
cut-offs for TBS and FN-BMD with the best compromise between
sensitivity and specificity obtained by ROC analysis (see text) and
set atK2.1 for TBS andK0.6 for BMD (both expressed as
Z-scores). The presence of the combination low TBS and/or low
FN-BMD showed a 95% SN, but a 28.8% SP, for detecting patients
at risk of fractures (two of the 40 PHPT patients with fractures did
not show low TBS and/or low FN-BMD and 37 of the 52 patients
without VFx showed low TBS and/or low FN-BMD). Open triangle,
patients without fractures; closed circle, patients with fractures.
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PZ0.14). The subjects with new VFx had no VFx
at baseline. They were younger (64.3G2.4 years) and
had similar BMI (28.1G2.4 kg/m2), urinary calcium
24 h/kg (0.08G0.03 mmol/day), serum calcium
(2.6G0.07 mmol/l) and PTH (129.3G62.9 ng/l)
levels compared with the seven patients without
new VFx (age 78.6G4 years, P!0.0001; BMI
27.5G3.7 kg/m2, PZ0.816; urinary calcium 24 h/kg
0.09G0.04 mmol/day, PZ0.353; serum calcium
2.6G0.1 mmol/l, PZ0.793 and PTH 108.7G49.2 ng/l,
PZ0.588). The prevalence of co-morbidities (i.e. dia-
betes mellitus, hypertension and cardiovascular disease)
was similar between these two groups (data not shown).
Discussion
The aim of this study was to evaluate the usefulness of
TBS alone or in combination with BMD for predicting
VFx in asymptomatic PHPT patients before and after
surgery or a conservative follow-up. We found that TBS
is reduced in PHPT and correlated with SDI. TBS was
associated with VFx regardless of BMD, age, BMI and
gender and showed the best accuracy for detecting
PHPT subjects with VFx compared with BMD, but the
combination low TBS plus low FN-BMD had the best
SP and the combination low TBS or low femoral BMD
(see Table 2) had the best SN for detecting patients
with VFx. After 24 months of follow-up, in surgically
treated patients, TBS increased significantly, while
in conservatively followed up patients, it tended to
decrease. In patients with new VFx of this latter group,
TBS decreased more than in those without new
fractures, while the BMD changes were comparable.
The data derived from the cross-sectional arm of this
study are in keeping with those of a recently publishedpaper of Romagnoli et al. (24), showing that, in PHPT
patients, TBS is reduced and more accurate than BMD in
detecting patients with VFx. At variance with that study,
however, in the present one the years since menopause
was not found to be an important parameter to use in
combination with TBS to detect patients with fractures.
This may be explained by the fact that in this study,
but not in the previous one (24), TBS data were adjusted
for age and expressed as Z values. This adjustment may
probably simplify the clinical use of TBS data. Indeed, the
data regarding the diagnostic accuracy (Table 2) suggest
that by simply using BMD and TBS, it is possible to find
out about the 70% of PHPT patients with asymptomatic
VFx (Fig. 1), with a similar SN and higher SP compared
with the study of Romagnoli et al. (24). Overall, these
data are of important clinical utility, as by combining
BMD and TBS data it could be possible to identify PHPT
patients at higher risk to have VFx, even if the high SN
(95%) of the combination low LS-BMD and/or low TBS
is obtained at the expense of a low SP (28.8%) (Fig. 1).
A new finding of this study is the association between
TBS and SDI in PHPT patients. This deserves interest as
SDI integrates both the number and the severity of VFx
(31, 32) and this latter parameter has been proposed as
a surrogate tool to assess bone quality (33). Therefore,
the association between SDI and TBS reinforces the
role of TBS as a parameter of bone quality also in PHPT
patients, in keeping with recent data showing that, in
these patients, TBS correlates with several indices of
trabecular micro-architecture (25). However, it iswww.eje-online.org
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www.eje-online.orgimportant to note that the risk of VFx in PHPT cannot
be attributed to changes in trabecular bone alone, as
PTH increases the cortical porosity and the cortical rim
accounts for about 40–50% of vertebral strength (35).
For the first time, the longitudinal data regarding the
TBS changes after the recovery from PHPT or after a
conservative follow-up are reported (Table 3). The lack
of new VFx in surgically treated patients did not allow
us to evaluate the possible role of TBS in predicting
incident VFx after recovery from PHPT. However, the
marked increase in TBS after recovery from PHPT
suggests that bone quality, besides bone density,
improves after resolution of PTH excess (Fig. 2). This
may be explained by the fact that, in the first few
months following parathyroidectomy, a positive
biochemical uncoupling occurs (36, 37), and sub-
sequently, both cortical and trabecular bone turnover
normalizes, with a reduction in cortical porosity and an
increase in trabecular bone volume (38, 39, 40).
In keeping with this, recent data show that, 1 year
after parathyroidectomy in female PHPT patients,
cortical bone geometry and cancellous bone architec-
ture improve and cortical and trabecular volumetric
BMD in both radius and tibia increase (41).
Conversely, the longitudinal data from the small
sample of conservatively followed up patients suggest
that bone quality decreases in the presence of persistent
PTH excess and reinforce the idea that TBS may have
an additive role, besides BMD, in detecting patients at risk
of VFx. Indeed, even if the statistical significance was not
reached, at variance with BMD values in conservatively
followed up subjects, mean TBS levels clearly decreased,
particularly in patients with new VFx.
The limits of this study may be related to the relatively
small sample of patients and to the absence of controls
included in the longitudinal arm of the study (particu-
larly in the conservative group) and to the lack of
matching between surgically treated and conservatively
followed up patients, with the latter group being older
than the former. Moreover, it should be noted that
control subjects were recruited from an outpatient clinic
and not from population-based controls and that the
available TBS normative data are in reference to a
different (i.e. French) population (34). However, the
changes of TBS in surgically treated PHPT subjects and
in those conservatively treated experiencing a new VFx
cannot be explained only by the different age and
suggest that TBS is useful in predicting the risk of
fracture in PHPT patients. Finally, due to budget
restriction, we could not measure BMD at the distal
1/3 of the radius that could possibly have been more
informative (42). However, in the study of Romagnoli
et al. (24), a subgroup of patients underwent a distal 1/3
radius BMD evaluation, which was not found to be more
accurate than TBS in detecting patients with fractures.
Overall, compared with the study of Romagnoli et al., we
found a similar moderate accuracy of TBS in predicting
VFx (AUC 0.73 and 0.74 respectively), while the newDownloaded from Bioscientifica.com at 10/22/2019 08:57:44AM
via Universita Degli Studi di Milano
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Figure 2 Trabecular bone score (TBS; expressed as Z-scores) in
control subjects and in all patients with primary hyperparathyroidism
(PHPT) at baseline, in 20 surgically treated patients with PHPT at
baseline and after a 24-month follow-up and in 10 conservatively
followed up patients with PHPT at baseline and after 24 months.
Bone quality in primary hyperparathyroidism 161EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013) 169findings are related to the use of Z-transformed TBS
values, which could simplify the clinical use of TBS data,
and to the longitudinal evaluation of the TBS changes in
patients with PHPT 2 years after the recovery or a
conservative follow-up.
Notwithstanding its limits, this study deserves clinical
interest, as it shows that with the combined use of TBS
and FN-BMD, the 70% of PHPT patients with VFx can
be detected and that in the conservatively followed up
PHPT patients, an important decrease in TBS values
could predict the occurrence of a VFx, in spite of the
absence of a clear BMD decrease.
In conclusion, our study shows that in PHPT: i) TBS is
reduced and associated with VFx regardless of BMD, age
or years since menopause, BMI and gender; ii) TBS has
higher diagnostic accuracy than BMD and may be used
together with BMD for identifying patients at risk of
VFx; and iii) after recovery TBS increases, while it seems
to decrease after a conservative follow-up in patients
experiencing new VFx.
Large cross-sectional and longitudinal intervention
studies are needed to assess the possible use of TBS in
the routine clinical practice for patients with PHPT.Declaration of interest
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